A detailed history of Davis R M Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Davis R M Inc holds 318,476 shares of MRK stock, worth $39.4 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
318,476
Previous 319,730 0.39%
Holding current value
$39.4 Million
Previous $34.9 Million 20.56%
% of portfolio
0.9%
Previous 0.82%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $142,002 - $165,465
-1,254 Reduced 0.39%
318,476 $42 Million
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $464,334 - $505,307
-4,635 Reduced 1.43%
319,730 $34.9 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $420,550 - $467,038
4,085 Added 1.28%
324,365 $33.4 Million
Q2 2023

Aug 10, 2023

BUY
$108.61 - $118.38 $230,035 - $250,728
2,118 Added 0.67%
320,280 $37 Million
Q1 2023

May 01, 2023

BUY
$102.94 - $114.86 $243,967 - $272,218
2,370 Added 0.75%
318,162 $33.8 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $272,200 - $348,998
3,113 Added 1.0%
315,792 $35 Million
Q3 2022

Nov 08, 2022

BUY
$84.53 - $94.96 $507,010 - $569,570
5,998 Added 1.96%
312,679 $26.9 Million
Q2 2022

Aug 08, 2022

BUY
$83.49 - $94.64 $217,324 - $246,347
2,603 Added 0.86%
306,681 $28 Million
Q1 2022

May 05, 2022

BUY
$73.51 - $82.4 $245,229 - $274,886
3,336 Added 1.11%
304,078 $25 Million
Q4 2021

Feb 08, 2022

BUY
$72.28 - $90.54 $595,081 - $745,415
8,233 Added 2.81%
300,742 $23 Million
Q3 2021

Nov 08, 2021

BUY
$71.68 - $78.83 $16,773 - $18,446
234 Added 0.08%
292,509 $22 Million
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $25,030 - $27,686
356 Added 0.12%
292,275 $22.7 Million
Q1 2021

May 10, 2021

BUY
$68.86 - $81.11 $58,393 - $68,781
848 Added 0.29%
291,919 $22.5 Million
Q4 2020

Jan 27, 2021

SELL
$71.77 - $79.65 $1.08 Million - $1.2 Million
-15,096 Reduced 4.93%
291,071 $23.8 Million
Q3 2020

Dec 01, 2020

BUY
$73.18 - $82.95 $805,565 - $913,113
11,008 Added 3.73%
306,167 $25.4 Million
Q2 2020

Jul 20, 2020

BUY
$70.42 - $80.13 $638,216 - $726,218
9,063 Added 3.17%
295,159 $22.8 Million
Q1 2020

Apr 24, 2020

BUY
$63.36 - $87.82 $246,913 - $342,234
3,897 Added 1.38%
286,096 $22 Million
Q4 2019

Jan 23, 2020

BUY
$77.58 - $87.54 $167,029 - $188,473
2,153 Added 0.77%
282,199 $25.7 Million
Q3 2019

Oct 24, 2019

BUY
$76.08 - $82.93 $356,282 - $388,361
4,683 Added 1.7%
280,046 $23.6 Million
Q2 2019

Jul 31, 2019

SELL
$69.84 - $81.59 $201,907 - $235,876
-2,891 Reduced 1.04%
275,363 $23.1 Million
Q1 2019

Apr 29, 2019

SELL
$69.58 - $79.36 $111,119 - $126,737
-1,597 Reduced 0.57%
278,254 $23.1 Million
Q4 2018

Jan 18, 2019

BUY
$65.24 - $75.71 $647,050 - $750,891
9,918 Added 3.67%
279,851 $21.4 Million
Q3 2018

Oct 17, 2018

BUY
$57.69 - $67.84 $16,037 - $18,859
278 Added 0.1%
269,933 $19.1 Million
Q2 2018

Jul 19, 2018

BUY
$50.83 - $59.72 $1.11 Million - $1.31 Million
21,901 Added 8.84%
269,655 $16.4 Million
Q1 2018

Apr 19, 2018

SELL
$50.96 - $59.23 $64,413 - $74,866
-1,264 Reduced 0.51%
247,754 $13.5 Million
Q4 2017

Jan 16, 2018

SELL
$51.62 - $61.64 $877,178 - $1.05 Million
-16,993 Reduced 6.39%
249,018 $14 Million
Q3 2017

Oct 24, 2017

BUY
$58.67 - $63.13 $15.6 Million - $16.8 Million
266,011
266,011 $17 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Davis R M Inc Portfolio

Follow Davis R M Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

News

Stay updated on Davis R M Inc with notifications on news.